MMP9 and metabolic dysfunction-associated steatotic liver disease: This study highlights the association of α-smooth muscle actin (α-SMA), a marker of activation of hepatic stellate cells, pro-MMP2, TIMP1 and TIMP2 with severity of fibrosis in NAFLD patients, whereas pro-MMP9 is rather associated with the severity of inflammation [245].